Sector consensus Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
06:59:50 13/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 302.27 USD | +0.10% |
|
+3.99% | +51.24% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 190.75 | +20.84% | 17 | |||||||
| 1,139.57 | +39.14% | 15 | |||||||
| 689.48 | +20.12% | 23 | |||||||
| 295.05 | +12.53% | 19 | |||||||
| 259.14 | +33.61% | 23 | |||||||
| 435.53 | +24.3% | 27 | |||||||
| 267,741.48 | +48.42% | 22 | |||||||
| 50.74 | +12.92% | 23 | |||||||
| 103.73 | +20.9% | 20 | |||||||
| 198.45 | +101.35% | 22 | |||||||
| 2,592.46 | +4.24% | 15 | |||||||
| 595.92 | -3.89% | 13 | |||||||
| 1,482.61 | +25.11% | 8 | |||||||
| 274.28 | +35.29% | 20 | |||||||
| 72.29 | -6.91% | 14 | |||||||
| 54.87 | -8.28% | 15 | |||||||
| 313.2 | +3.76% | 15 | |||||||
| 22.51 | +73.63% | 13 | |||||||
| 619.67 | +37.77% | 19 | |||||||
| Average | 14,585.88 | +26.04% | 18 | ||||||
| Weighted average by Cap. | 15,797.53 | +26.26% | 19 |
Select your edition
All financial news and data tailored to specific country editions
















